BONE BIOLOGICS CORP (BBLG) Forecast, Price Target & Analyst Ratings
NASDAQ:BBLG • US0980706008
1.28 USD
0 (0%)
At close: Mar 11, 2026
1.29 USD
+0.01 (+0.78%)
After Hours: 3/11/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BONE BIOLOGICS CORP (BBLG).
Forecast Snapshot
Consensus Price Target
$22.70
+ 1,673.05% Upside
Next Earnings Forecast
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$0.55
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$22.70
Upside
+ 1,673.05%
From current price of $1.28 to mean target of $22.70, Based on 7 analyst forecasts
Low
$22.47
Median
$22.70
High
$23.36
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for BBLG. The average price target is 22.7 USD. This implies a price increase of 1673.05% is expected in the next year compared to the current price of 1.28.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
BBLG was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBLG.
In the previous month the buy percentage consensus was at a similar level.
BBLG was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-04-13 | EF Hutton | Reiterate | Buy |
| 2023-04-03 | EF Hutton | Reiterate | Buy |
| 2022-10-18 | EF Hutton | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$0.55
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q71.31%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
BBLG is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.55 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | ||||||||||||
| EBITDA YoY % growth | -12M | -20.41M -70.08% | -2.63M 87.11% | -2.79M -6.08% | -2.45M 12.19% | -830K 66.12% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12M | -20.41M -70.08% | -2.63M 87.11% | -2.79M -6.08% | -2.45M 12.19% | -830K 66.12% | -1.1M -32.53% | -3.67M -233.64% | -9.428M -156.90% | -4.219M 55.25% | -3.235M 23.33% | N/A 5.66% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -604.80 37.61% | -398.34 34.14% | -29.78 92.52% | -3.76 87.38% | N/A 63.11% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | |
|---|---|
| EPS Q2Q % growth | -0.55 71.31% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -757.86K 27.02% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BONE BIOLOGICS CORP / BBLG Forecast FAQ
What do analysts expect the price target to be for BONE BIOLOGICS CORP (BBLG)?
7 analysts have analysed BBLG and the average price target is 22.7 USD. This implies a price increase of 1673.05% is expected in the next year compared to the current price of 1.28.
Can you provide the upcoming earnings date for BONE BIOLOGICS CORP?
BONE BIOLOGICS CORP (BBLG) will report earnings on 2026-05-11.
What are the consensus estimates for BBLG stock next earnings?
The consensus EPS estimate for the next earnings of BONE BIOLOGICS CORP (BBLG) is -0.55 USD and the consensus revenue estimate is 0 USD.
What is the consensus rating for BBLG stock?
The consensus rating for BONE BIOLOGICS CORP (BBLG) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.